COVID-19 does not impact HLA antibody profile in a series of waitlisted renal transplant candidates
- 1 August 2021
- journal article
- research article
- Published by Elsevier in Human Immunology
- Vol. 82 (8) , 568-573
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- A Virtual Crossmatch-based Strategy Facilitates Sharing of Deceased Donor Kidneys for Highly Sensitized RecipientsTransplantation, 2020
- Allo-HLA Cross-Reactivities of Cytomegalovirus-, Influenza-, and Varicella Zoster Virus–Specific Memory T Cells Are Shared by Different Healthy IndividualsAmerican Journal of Transplantation, 2017
- Infectious pathogens may trigger specific allo-HLA reactivity via multiple mechanismsImmunogenetics, 2017
- Epidemiology and Immediate Indirect Effects of Respiratory Viruses in Lung Transplant Recipients: A 5-Year Prospective StudyAmerican Journal of Transplantation, 2016
- The Impact of Infection on Chronic Allograft Dysfunction and Allograft Survival After Solid Organ TransplantationAmerican Journal of Transplantation, 2015
- Assessing Antibody Strength: Comparison of MFI, C1q, and Titer InformationAmerican Journal of Transplantation, 2015
- De Novo Anti-HLA Antibody After Pandemic H1N1 and Seasonal Influenza Immunization in Kidney Transplant RecipientsAmerican Journal of Transplantation, 2011
- Cross-Reactivity of Herpesvirus-Specific CD8 T Cell Lines Toward Allogeneic Class I MHC MoleculesPLOS ONE, 2010
- Allo-HLA reactivity of virus-specific memory T cells is commonBlood, 2010
- The ‘Indirect’ Effects of Cytomegalovirus InfectionAmerican Journal of Transplantation, 2009